Unchanged Infliximab Serum Concentrations After Switching...

Unchanged Infliximab Serum Concentrations After Switching from the Originator Infliximab to the Biosimilar CT-P13 in Patients with Quiescent Crohn's Disease: A Prospective Study

Strik, Anne S., de Vrie, W van, Megen, Yvonne, Minekus, Joanne, Rispens, Theo, D'Haens, Geert R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(17)30573-5
Date:
April, 2017
File:
PDF, 1.39 MB
english, 2017
Conversion to is in progress
Conversion to is failed